Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301066 · ClinicalTrials.gov registry record · Phase 4
A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
A Phase 4 study of Dyslipidemia, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 252
- Enrollment target
- 20
- Study locations
NCT01301066: Completed Phase 4 study of Dyslipidemia, sponsored by Kowa Research Institute.
NCT01301066 is a Phase 4 study of Dyslipidemia that has completed, run by Kowa Research Institute. The registered enrollment target is 252 participants, below the 357-participant average among 40 other Dyslipidemia trials with a reported enrollment target (29% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01301066, a Phase 4 study of Dyslipidemia, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 252 participants
- Enrollment target
- 20
- Study locations
Study Summary
A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.
Conditions Studied
Interventions
- DRUG Pravastatin
- DRUG Pitavastatin
Study Locations (20)
Florida
- - Coral Gables
- - Fort Lauderdale
- - Ft. Pierce
- - Miami
- - Miami Beach
- - Tampa
- - Vero Beach
California
- - Beverly Hills
- - Costa Mesa
- - Long Beach
- - Los Angeles
- - Newport Beach
- - San Francisco
Georgia
- - Atlanta
- - Decatur
Arizona
- - Phoenix
District of Columbia
- - Washington D.C.
Massachusetts
- - Springfield
Michigan
- - Berkley
Missouri
- - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
What the finished NCT01301066 record still lists
NCT01301066 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 40 other Dyslipidemia trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 2 interventions - of which Pravastatin is the first listed.
NCT01301066 names 20 study sites across 8 states, led by Florida, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT01301066 about?
NCT01301066 is a clinical study titled "A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects". A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.
What is the current status of trial NCT01301066?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 252 participants. The study started on 2010-12. Estimated completion is 2013-03.
What conditions does trial NCT01301066 study?
This clinical trial studies the following conditions: Dyslipidemia.
What interventions are being tested in trial NCT01301066?
The interventions under investigation include: Pravastatin (DRUG), Pitavastatin (DRUG).
Who is sponsoring clinical trial NCT01301066?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01301066 being conducted?
This trial has 20 study locations across Arizona, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyslipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01301066's enrollment target sits among peer trials
252 11th of 40 higher than 30 of 40 other Dyslipidemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyslipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fluvastatin in Adults With Dislipidemia With History of Muscle Problems
COMPLETED · Phase 4
-
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
COMPLETED · Phase 4
-
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
COMPLETED · Phase 4
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia